0001637931-19-000001.txt : 20190226 0001637931-19-000001.hdr.sgml : 20190226 20190226153530 ACCESSION NUMBER: 0001637931-19-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190226 DATE AS OF CHANGE: 20190226 EFFECTIVENESS DATE: 20190226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Semma Therapeutics, Inc. CENTRAL INDEX KEY: 0001637931 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-300037 FILM NUMBER: 19633204 BUSINESS ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: STE 2B CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-901-4221 MAIL ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: STE 2B CITY: CAMBRIDGE STATE: MA ZIP: 02142 D/A 1 primary_doc.xml X0708 D/A LIVE 0001637931 Semma Therapeutics, Inc. 450 KENDALL STREET STE 2B CAMBRIDGE MA MASSACHUSETTS 02142 857-529-6430 DELAWARE None None Corporation true 2014 Bastiano Sanna 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Todd Foley 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Stephen Knight 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Mitchell Finer 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Kingsley Taft 100 Northern Ave Boston MA MASSACHUSETTS 02210 Executive Officer Mark Fishman 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director William Sahlman 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Kevin Raidy 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Daniel Auerbach 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b true 0001637931-17-000002 2017-11-27 true true false 0 119860708 113860712 5999996 Series B Preferred Stock. Total amount sold includes $13,860,712 from note conversions. false 20 0 0 0 false Semma Therapeutics, Inc. /s/Bastiano Sanna Bastiano Sanna Chief Executive Officer 2019-02-26